This HTML5 document contains 206 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36553506
rdf:type
wikibase:Item
schema:description
artigo científico наукова стаття, опублікована в травні 2013 2013年论文 2013年论文 naučni članak სამეცნიერო სტატია videnskabelig artikel 2013年論文 scienca artikolo مقالة علمية نشرت في 13 مايو 2013 2013 nî lūn-bûn ১৩ মে ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikel ilmiah artigo científico scientific article published on 13 May 2013 2013年论文 artículu científicu espublizáu en 2013 artículo científico publicado en 2013 artykuł naukowy bilimsel makale artikulong pang-agham 2013年论文 научна статия 2013年論文 2013년 논문 scientific article published on 13 May 2013 научни чланак tieteellinen artikkeli bài báo khoa học article scientific articol științific 2013年論文 scientific article published on 13 May 2013 מאמר מדעי บทความทางวิทยาศาสตร์ vitenskapelig artikkel 2013年論文 teaduslik artikkel articolo scientifico wetenschappelijk artikel 2013年の論文 vetenskaplig artikel artigo científico επιστημονικό άρθρο 2013年论文 tudományos cikk научная статья vitskapeleg artikkel vedecký článok мақолаи илмӣ 2013年論文 vědecký článek article scientifique article científic artikull shkencor 2013年论文 wissenschaftlicher Artikel научни чланак
p:P577
wds:Q36553506-14430B33-568D-4EC5-8630-484674FB0B71
wdt:P577
2013-05-13T00:00:00Z
p:P407
wds:Q36553506-D8F55BF1-9AF9-463F-BF0F-9B5E4CE703A7
wdt:P407
wd:Q1860
p:P2860
wds:Q36553506-38830627-B220-4353-874B-665FBEAF3587 wds:Q36553506-38FCC1D8-F15B-4314-A90C-117D8141CCE2 wds:Q36553506-3A041161-A4B8-4C06-B9B4-86B48EE3EB03 wds:Q36553506-3A787B55-59A9-4D39-84F7-D0EAF2E0F46D wds:Q36553506-2E5CC2A2-45CE-40D7-87A1-3F8559A7B52B wds:Q36553506-54A123F7-E9C5-4768-AEE4-552BC6306DCF wds:Q36553506-5EEF4817-836F-4E47-AA9F-340E30ACD600 wds:Q36553506-636F0DA2-A488-469B-84D2-45EC654AA61D wds:Q36553506-3DB57996-B26F-4116-9B03-188EEA5165AF wds:Q36553506-41692EF5-2D0B-43FC-B4EE-D4D0CF322C06 wds:Q36553506-462494BB-A214-468D-8FB0-64FB72667BC0 wds:Q36553506-4E89699D-F4F9-48D5-9E1B-FA2FCF5FC3C7 wds:Q36553506-7FF520BA-A545-4BEC-BAD6-9A3947E92FBC wds:Q36553506-83C7962F-8E73-4121-9101-6161DDE7DAB3 wds:Q36553506-84A30C24-96A0-4703-862E-6C3E846C15B8 wds:Q36553506-858A12CA-2428-4F51-8560-F623BCABA92A wds:Q36553506-653EC8C7-0165-449C-AECC-DC69DD209F5C wds:Q36553506-769E45EA-E346-42C7-9312-133243F381C4 wds:Q36553506-9D55823E-8BA9-479D-B4C3-FE8786354B9E wds:Q36553506-9FB8F927-219D-45B6-8B83-C4A2816C5B85 wds:Q36553506-A556F78F-4024-4C81-A39A-D1920FAB3408 wds:Q36553506-A6907587-443E-4D38-8F9B-663F07FA688E wds:Q36553506-8D2A3A78-7202-4439-8A15-B542FC2A746B wds:Q36553506-98EC984C-F263-4EF8-B745-FA40986C97B2 wds:Q36553506-9AAEA01E-12EC-4874-91FF-DFC0CEC9C0EA wds:Q36553506-11947AE1-5E63-4A95-A317-E5AFD56293AD wds:Q36553506-141EFC01-696D-4957-8CDC-BD4255D8B8B9 wds:Q36553506-1F09A2A1-3214-4D20-90A8-53F0D14DCBD1 wds:Q36553506-2660F0D2-4499-429B-BFAB-377CE60F569A wds:Q36553506-28C4B0AE-F25A-468F-A329-3AEFA9775126 wds:Q36553506-14E94A20-C00F-4486-BC85-608E3CB78B2A wds:Q36553506-14ECD3E5-DA4A-4A0E-90C9-72CFD3F5EDFC wds:Q36553506-B1EA87E0-E49F-4460-864F-7A150F6009F4 wds:Q36553506-BDBBA55E-E6C6-457F-B920-FE832E13F3A5 wds:Q36553506-AD4D3A97-4B86-4B78-8F99-81DB6C3A88DF wds:Q36553506-AF61B75C-CEFC-49FF-9D1C-E3C3ACCDECA6 wds:Q36553506-B0D2C34C-9D58-4D21-B98F-92B939EB9E7D wds:Q36553506-CDE59B73-0DA3-4E1A-8D35-E332621DED7E wds:Q36553506-D43C95B3-F85A-4B63-AD18-C5A2B4F62B53 wds:Q36553506-C15A3AB6-9130-4D56-BA71-5C8B6FDC886C wds:Q36553506-C708F937-F1A7-410F-9951-9EE91DD61030 wds:Q36553506-CD721787-2E1F-42B2-B697-17ACE04EB77E wds:Q36553506-F04D6C1F-0AF0-4CB9-B2B5-E6D8483BC217 wds:Q36553506-F49F3354-7723-4BE5-A588-DC12BD791400 wds:Q36553506-F5DEB33A-4D19-4C33-B0D2-7FC518F5EBBD wds:Q36553506-ECD7A8DD-2F57-427E-A638-D1B307FDABF4 wds:Q36553506-F00E79C0-EA93-427E-A210-7EF1EFAC4425 wds:Q36553506-F93EAC2E-7524-47B3-9A1C-A2B2B864A353 wds:Q36553506-F9CD7D50-ADC2-4C30-877D-84A181335231
wdt:P2860
wd:Q46794540 wd:Q37224099 wd:Q43266784 wd:Q46988508 wd:Q28278528 wd:Q41637516 wd:Q44571738 wd:Q44634009 wd:Q46463184 wd:Q44534981 wd:Q46825147 wd:Q43275775 wd:Q36731919 wd:Q46500802 wd:Q85781295 wd:Q34095813 wd:Q34570396 wd:Q80061623 wd:Q53591340 wd:Q81407226 wd:Q41904942 wd:Q80439595 wd:Q51522929 wd:Q46802463 wd:Q44456773 wd:Q41489196 wd:Q79792655 wd:Q40147036 wd:Q43123333 wd:Q46438797 wd:Q37018333 wd:Q29547556 wd:Q45969997 wd:Q34152748 wd:Q37179393 wd:Q27860574 wd:Q36420481 wd:Q34617892 wd:Q46691725 wd:Q40333505 wd:Q42618799 wd:Q34002513 wd:Q36931345 wd:Q34976147 wd:Q83611066 wd:Q51803777 wd:Q44628533 wd:Q43968160 wd:Q37110398
p:P2093
wds:Q36553506-304806B0-B3C7-425B-B9CB-8899DC16B703 wds:Q36553506-EDF7A7DB-2D1C-45DB-AF2A-4F8A84C48567 wds:Q36553506-BF5DEA33-79D1-4B2A-A247-48E5BCE7873B wds:Q36553506-1A9F3189-6073-463D-A364-FBD2167223F2 wds:Q36553506-7FD840C2-951B-48DD-9E0D-FF03D1A97011
wdt:P2093
Kurt Miller Robert E Coleman Cora N Sternberg Benjamin A Gartrell Matthew D Galsky
rdfs:label
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
skos:prefLabel
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
schema:name
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
p:P50
wds:Q36553506-6A96EB97-F1E6-4B4C-BA18-BF54B3E92727 wds:Q36553506-64904F07-F24C-42E8-A22A-F98308BF3D34
wdt:P50
wd:Q73569107 wd:Q88065306
p:P1476
wds:Q36553506-37990B48-B88B-4303-984B-6E40E47C191F
wdt:P1476
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
p:P304
wds:Q36553506-CCE6A22A-D19C-402F-BEC1-A4472420A98B
wdt:P304
278-286
p:P31
wds:Q36553506-2C207018-DB4A-428B-ACF9-5555104C08A7
wdt:P31
wd:Q13442814
p:P921
wds:Q36553506-F292A02C-72EA-48B0-BFBA-F9A43F8BB0BD
wdt:P921
wd:Q181257
p:P698
wds:Q36553506-AB576513-2CEA-4883-9DCE-190C918B0436
wdtn:P698
n11:23706567
wdt:P698
23706567
p:P1433
wds:Q36553506-B5B0354A-835F-4E10-889E-299118C0724A
wdt:P1433
wd:Q15763991
p:P433
wds:Q36553506-E1601FB3-49D2-4FB3-8505-82336626B6B6
p:P478
wds:Q36553506-2E6B9482-3F0B-4FE0-A8F5-A15F57D01198
wdt:P433
2
wdt:P478
65
p:P356
wds:Q36553506-ECE2EA57-673B-470C-9A8A-CF3E4CD55D73
wdtn:P356
n12:J.EURURO.2013.05.015
wdt:P356
10.1016/J.EURURO.2013.05.015
p:P932
wds:Q36553506-9CB035D2-413F-440D-AE8C-C225A9650D8A
wdt:P932
4744484